New Jersey Medical School Clinical Research Center is the only site in the state participating in a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade. To read the full article.
Recent Posts
- Scientists Develop Plastics That Can Break Down, Tackling Pollution.
- NJACTS Community Engagement Core COVID-19 Resources
- N.J. Gov. Phil Murphy urges microplastics regulations in tap water. Can water providers meet the challenge?
- Could Hidden Infections Be Fueling Long COVID?
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
Categories
- Community (2,428)
- Covid (996)
- CTO Events (6)
- News (3,074)
- Pilots (21)